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The human 02-interferon/hepatocyte-stimulating factor/interleukin 6 (IFN-02/IL-
6) gene on chromosome 7p15-p21 codes for a set of at least five secretory glycopro-
teins of molecular mass in the range from 23-30 kD that mediate acutephase plasma
protein secretion by hepatocytes and that regulate several different aspects of the
host immune response (1-5). In addition to mediating many of the alterations in
acute phase plasma protein secretion by hepatocytes, proteins derived from the IFN-
02/IL-6 gene elicit an antiviral state, enhance proliferation of murine hybridoma
cells, enhance proliferation of human B cellsrecently transformed by EBV, enhance
secretion of Igs by human B cell lines, contribute to the proliferation of murine and
human thymocytes and T cells, enhance colony formation by hematopoietic pro-
genitor cells, and mediate a pyrogenic response to tissue damage (reviewed in 4-9).
This multifunctional cytokine has emerged as a major component in the host re-
sponse to noxious stimuli, such as bacterial infections and tissue damage, such as
that after severe burns (reviewed in 4, 9). It is secreted by fibroblasts, monocytes,
keratinocytes, endothelial cells, and various other epithelial and mesenchymal cells
(4, 6, 8, 10, 11). Typically, the expression of IFN-02/IL-6 proteins is enhanced in
response to other cytokines such as IL-1, TNF, lymphotoxin, platelet-derived growth
factor and other IFN, and to poly(I)-poly(C)(reviewed in 5, 12). Bacterial products
such as endotoxin also strongly enhance expression and secretion of IFN-02/IL-6
by monocytes (4, 6, 8, 10) and fibroblasts (4, 13). Thus, the regulation of expression
of the IFN-02/IL-6 gene is clearly well-adapted to participation of this cytokine in
the host response to tissue damage. In the present article, we report that the ubiqui-
tous stromal fibroblast secretes this multifunctional cytokine in response to acute
viral infections. These data suggest that IFN-02/IL-6 is likely to be a component
in the host response to viral pathogens.
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Materials and Methods
The human diploid foreskin fibroblast strain FS-4 was used throughout; procedures for
its growth in cell culture, for IFN-02/IL-6 mRNA induction, for RNA blot-hybridization
analyses, and for "S-methionine-labeling of secreted IFN-02/IL-6 proteins have been de-
scribed earlier (4, 12, 13). The human hepatoma cell line Hep3B clone 2 was obtained from
the American Type Culture Collection, Rockville, MD (No. HB8064). Hep3B2 cells were
grown in T-75 flasks in Eagle's MEM supplemented with 10% (vol/vol) heat-inactivated FCS
(Gibco, Grand Island, NY), 0.1 mM pyruvate (Gibco), and "MEM nonessential amino acids"
(Gibco). The procedure for assaying hepatocyte-stimulating factor activity (increased syn-
thesis and secretion of at-antichymotrypsin) has been described elsewhere (4). Medium from
virus-infected FS-4 cell cultures was centrifuged at 40,000 rpm for 90 min in an SW50 .1 rotor
(Beckman Instruments, Inc., Palo Alto, CA) and then y-irradiated (90,000 rad) before addi-
tion to hepatocyte cultures.
Virus Stocks and Procedurefor Infection of Fibroblasts.
￿
Seed stocks of Sendai and Newcastle
disease viruses were passaged in embryonated chicken eggs. Egg-grown Sendai and New-
castle disease virus preparations had titers of 8,000 and 4,000 hemagglutination units (HAU)
per ml, respectively (1 HAU/ml corresponds to -105 plaque forming units (PFU) per ml).
Vesicular stomatitis virus (Indiana strain) was grown in chicken embryo fibroblast cultures
(titer in the range of 10'-to 10' PFU/ml). Encephalomyocarditis virus was grown in murine
L cell cultures (titer 6 x 10' PFU/ml). Influenza virus type A strains WSN and Udorn (titers
in the range of 1,000-4,000 HAU/ml) were grown in embryonated chicken eggs. Pseudora-
bies virus was grown in HeLa cells (titer 4.8 x 10' PFU/ml). Adenovirus type 5 grown in
HeLa cells was purified through a cesium chloride gradient (titer 6.4 x 10'2 virus parti-
cles/ml). Hyperimmune horse anti-Sendai virus antiserum was used in some of the neutral-
ization experiments.
Confluent cultures of FS-4 cells in T175 flasks 5-8 d after the previous medium change
were rinsed twice with PBS and then incubated with 2 ml/flask of Eagle's MEM containing
the virus at an appropriate concentration. The virus was allowed to adsorb for 1-1 .5 h at
37°C, the cell sheets were then washed 10 times with PBS, and the flasks were replenished
with either Eagle's MEM supplemented with 5% FCS or with the appropriate medium for
"'IS-methionine labeling.
Measurement ofBacterial LPS(Endotoxin) Levels.
￿
Endotoxin levels in the different virus prepa-
rations at the highest concentrations used in Fig. 1 were measured using the QCL-1000 Quan-
titative Chromogenic Limulus Amebecyte Lysate assay kit (Whittaker M . A. Bioproducts,
Walkersville, MD) calibrated using an Escherichia coli strain 0111:134 endotoxin standard . In
this assay, which was verified to be linear in the range of0.1-1.0 endotoxin U/ml (10-100 pg/ml),
only the pseudorabies virus preparation contained a measurable level ofendotoxin (-50 pg/ml).
This concentration has already been shown to be insufficient to affect IFN-02/IL-6 gene ex-
pression in human diploid fibroblasts (13).
Results and Discussion
Enhancement of IFN-/IZ/IL-6 mRNA Levels in Virus-infected Fibroblasts.
￿
Fig. 1
presents an overview of the ability of RNA- and DNA-containing viruses belonging
to different subgroups to induce IFN-a2/IL-6 mRNA in human fibroblasts. In this
experiment, the virus concentration used in each case was the highest that could
be added to the cultures given the titers ofthe various virus stocks (virus stocks were
diluted from 1:20-1:100; estimated multiplicities of infection in the range of 0.1-2
PFU/cell). It is clear from Fig. 1 that different virus preparations differ markedly
in their ability to induce IFN-R2/IL-6. The Sendai virus (paramyxoviridae) prepa-
ration was the strongest inducer (10-fold enhancement) from among the different
RNA-containing virus preparations tested; the pseudorabies virus (herpesviridae)
preparation was the strongest inducer (sixfold enhancement) from among the DNA-SEHGAL ET AL. BRIEF DEFINITIVE REPORT
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FIGURE 1 .
￿
Induction of IFN-02/IL-6 mRNA in
human fibroblasts by virus infection . Confluent
monolayers ofFS-4 cells in T-175 flasks (2 flasks
per group) were exposed for 1 .5 h to different
viruses, rinsed thoroughly with PBS, and then in-
cubated for another 6 h in Eagle's MEM . The
levels of IFN-02/IL-6 mRNA were monitored by
agarose gel electrophoresis followed by blot hy-
bridization using a human IFN-02/IL-6 cDNA
probe (P02 .15) . Lane C is uninfected control ; the
other lanes illustrate mRNA from virus-infected
cell cultures. The virus stock was diluted 1:20 in
the case of Sendai, NDV, PR, and Flu (WSN
strain); 1:40 in the case ofVSV and EMC ; and
1 :100 in the case of Ads . By densitometric scan-
ning, the relative content of IFN-02/IL-6 mRNA
was 9 .6-, 1 .8-, 3-, 5 .3-, 5.7-, 1 .1-, and 1.3-fold in
Sendai-, NDV-, VSV-, EMC-, PR-, Ad5-, or
Flu-infected cultures, compared with that in unin-
fected cultures .
containing virus preparations tested . EMC (picornaviridae) andVSV (rhabdoviridae)
also clearly enhanced IFN-02/IL-6 mRNA levels by 6-8 h after virus infection in
this experiment (Fig.l) .
At 6 h after infection, an enhancement in IFN-02/IL-6 mRNA levels is seen in
fibroblasts infected with Sendai virus at 1 HAU/ml (multiplicity of infection -0.002
PFU/cell) (not shown) . The induction of IFN-02/IL-6 by Sendai virus can be
blocked by incubating the virus with hyperimmune antiserum to the virus, suggesting
that it is virus infection that triggers the enhancement of IFN-(32/IL-6 gene expres-
sion (not shown) . An enhancement in IFN-PAL-6 mRNA levels is also seen using
pseudorabies (PR) virus at a multiplicity of infection as low as 0 .001 PFU/cell (not
shown) . Thus infection of as few as 10,000-100,000 cells per culture (a T-175 flask
contains -5 x 10 7 cells) with Sendai or pseudorabies virus is sufficient to yield a
detectable increase in accumulation of IFN-(32/IL-6 mRNA .
Secretion of IFN-021IL-6 Proteins by Virus-infected FS-4 Cells .
￿
Cytokine- or endo-
toxin-induced human fibroblasts secrete two different sets of IFN-R2/IL-6 proteins :
N- and 0-glycosylated species ofmolecular mass 28, 29, and 30 kD, and 0-glycosylated
species of molecular mass 23 and 25 KD (4 ; our unpublished data). These can be
detected by electrophoresis through highly resolving gels of immunoprecipitates of
35S-methionine-labeled proteins from the culture medium of induced cells using a
rabbit antiserum to human IFN-02/IL-6 protein expressed in E. colt (4) . Figs . 2 and
3 summarize the observation that FS-4 cell cultures infected with Sendai, EMC,
VSV, Flu, PR, or Ad5 viruses synthesize and secrete enhanced levels of IFN-02/IL-6
into the culture medium (2-15-fold increase) . In these gels, the 28-30-kD species
are clearly resolved from the 23-25-kD proteins . The relative levels of IFN-02/IL-6
secretion observed approximately correlate with the RNA blot-hybridization data
in Fig . 1 . It is remarkable that even as the EMC-infected cells are undergoing patho-
logical changes (note the additional high molecular mass protein bands that con-
taminate the immunoprecipitate, particularly at the higher multiplicity of infection),
the cultures continue to secrete high levels of IFN-02/IL-6 (Fig . 2) .1954 SEHGAL ET AL . BRIEF DEFINITIVE REPORT
FIGURE 2 . Synthesis and secretion of IFN-
02/IL-6 proteins by human fibroblasts infected
with Sendai, encephalomyocarditis, and vesicular
stomatitis viruses . 3'S-methionine-labeled IFN-
02/IL-6 proteins secreted over a 6-h period by
virus-infected FS-4 cells were analyzed by immu-
noprecipitation using rabbit antiserum to E .
coli-derived IFN-02/IL-6 followed by SDS-PAGE
and autoradiography. Different dilutions of each
of the three viruses were evaluated: Sendai lane
1, 1 :80 dilution ofvirus stock ; lane 2, 1:320 ; lane
3, 1 :1,280; EMC lane 1, 1:80 ; lane 2, 1:320; lane
3, 1 :1,280 ; VSV lane 1, 1:80 ; lane 2, 1:320 . By
densitometric scanning, there is up to a 15-, 9-,
and 13-fold increase in IFN-P2/IL-6 synthesis
and secretion by Sendai-, EMC-,orVSVinfected
FS-4 cells, respectively.
Thus, although the RNA data in Fig. 1 did not reveal a clear enhancement in
IFN-02/IL-6 mRNA levels after Ad5 or Flu infection (this experiment represents
a comparison ofmRNA levels at one particular time after virus infection), monitoring
of the cumulative synthesis and secretion of IFN-R2/IL-6 over a 6-h period (Fig . 3)
reveals increased production of the cytokine (also see Fig . 4) .
In additional experiments, we have observed that stimulation of FS-4 cells with
different concentrations of Sendai or PR viruses combined with bacterial LPS in
the concentration range of 100-10 ng/ml did not display any synergistic or even an
additive enhancement of IFN-02/IL-6 protein secretion (not shown) . The induction
of IFN-02/IL-6 proteins by the viral stimuli was the dominant determinant in these
experiments .
Hepatocyte-stimulating Activity ofMediumfrom Virus-infected FS-4 Cell Cultures .
￿
The
outstanding biological effect of IFN-02/IL-6 is its ability to elicit the major acute
phase alterations in plasma protein secretion by hepatocytes . We have evaluated
medium from virus-infected FS-4 cell cultures for its ability to enhance at-
antichymotrypsin secretion by human hepatoma Hep3B2 cells ; secretion of at-
antichymotrypsin by hepatocytes is enhanced by IFN-R2/IL-6 but not by other
cytokines such as TNF (6) . Fig . 4 illustrates an experiment showing the enhanced
synthesis and secretion of the positive acute phase protein al-antichymotrypsin by
Hep3B2 cells exposed to culture media from FS-4 cells infected with Sendai, NDV
FIGURE 3.
￿
Synthesis and secretion of IFN-02/IL-6
proteins by human fibroblasts infected with pseudora-
bies virus, adenovirus type 5, andinfluenza(Udorn)
viruses. Theexperiment was carried out as mentioned
in legend to Fig . 2 ; only the21-31-kD region of the
autoradiogram is illustrated . Different dilutions of
each ofthe three viruseswere evaluated : PR lane 1,
1:10 dilution of virus stock ; lane 2, 1:100 ; Ad5 lane
1, 1 :100; lane 2, 1:1,000 ; Flu lane 1, 1:10 ; lane 2, 1:100 .
By densitometric scanning, the synthesis and secre-
tion of IFN-02/IL-6 is increased 6-, 2.3-, and 4-fold
by PR-, Ad5-, or Flu-infected FS-4 cells, respectively.SEHGAL ET AL. BRIEF DEFINITIVE REPORT
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FIGURE 4.
￿
Culture media from virus infected human fibro-
blasts enhance acute phase plasma protein secretion by hepa-
tocytes . Human Hep3B2 cells in 24-well multiwell plates were
exposed to a 1:5 dilution of ultracentrifuged and irradiated
samples of mediafrom FS-4 cell cultures infected with Sendai,
NDV, VSV, Ad5, andFlu as described in legend to Fig . 1 . The
synthesis and secretion ofal'-antichymotrypsin wasevaluated
by labeling the Hep3B2 cells with "S-methionine followed by
immunoprecipitation of the labeled protein from the culture
medium ; the immunoprecipitates were analyzed by SDS-PAGE
andautoradiography. By densitometric scanning, therewasan
8-15-fold increase in al-antichymotrypsin secretion in this
assay when Hep3B2 cells were exposed to media from virus-
infected fibroblasts . Hep3B2 cells treated with media from
EMC- or PR-infected FS-4 cells rapidly lifted off the substratum .
VSV, Ad5, or Flu viruses (8-15-fold enhancement) . Culture media from EMC and
PR-infected fibroblasts had cytocidal effects on Hep3B2 cells ; thus these assays are
not shown .
In this article, we report that virus infection strongly enhances the expression and
secretion of IFN-R2/IL-6 proteins by the ubiquitous stromal fibroblast . The secreted
IFN-02/IL-6 may mediate aspects of the host response (acute phase and immune)
to viral infections and may itself contribute to the symptoms of viral disease such
as pyrexia (recombinant E . toll'-derived human IFN-R2/IL-6 has been reported to
be highly pyrogenic ; see reference 9) . The development of assays that detect IFN-
02/IL-6 in body fluids (9), the cloning and expression of the murine IFN-02/IL-6
gene, and the availability of serologic reagents that neutralize IFN-02/IL-6 (4) now
permit an evaluation of the biological importance of IFN-02/IL-6 in human and
murine virus infections .
Summary
We have defined the expression of the mRNA for, and secretion of, IFN-R2/hepa-
tocyte-stimulating factor/IL-6 (IFN-R2/IL-6) in human diploid fibroblasts (FS-4
strain) infected with different RNA- and DNA-containing viruses . RNA blot-
hybridization analyses carried out 6-8 h after the beginning of infection showed that
the RNA-containing Sendai virus (paramyxoviridae) enhanced IFN-R2/IL-6 mRNA
levels 10-fold, followed, in decreasing order, by encephalomyocarditis (EMC, picor-
naviridae), vesicular stomatitis (VSV, rhabdoviridae), Newcastle disease virus (NDV,
paramyxoviridae), and influenza A (Flu, myxoviridae) viruses . The DNA-containing
pseudorabies virus (PR, herpesviridae) enhanced IFN-02/IL-6 mRNA levels sixfold,
while the effect of adenovirus type 5 (Ad5, adenoviridae) was considerably less and
comparable with that ofNDV or Flu . A rabbit antiserum raised against E. coli-de-
rived human IFN-02/IL-6 was used in immunoprecipitation experiments to mon-
itor the secretion of "S-methionine-pulse-labeled IFN -02/IL-6 proteins by fibro-
blasts up to 7 h after the beginning of infection . Enhanced levels of secretion of
IFN-02/IL -6 (2-14-fold) were observed in every instance evaluated (Sendai, EMC,
VSV, Flu, PR, Ad5 viruses) . A biological consequence of enhanced secretion ofIFN-
(32/IL-6 was the ability ofmedia from infected FS-4 cell cultures to enhance by 8-15-
fold the synthesis and secretion of a typical acute phase plasma protein (a,-1956
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antichymotrypsin) by human hepatoma Hep3B2 cells. These observations make it
likely that IFN-PAL-6 mediates, in part, the host response to acute virus infections.
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